Total Payments
$136,591
2024 Payments
$62,211
Companies
6
Transactions
138
Payment Breakdown by Category
Consulting$107,576 (78.8%)
Travel$25,409 (18.6%)
Food & Beverage$3,587 (2.6%)
Education$19.08 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $107,576 | 37 | 78.8% |
| Travel and Lodging | $25,409 | 53 | 18.6% |
| Food and Beverage | $3,587 | 45 | 2.6% |
| Education | $19.08 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | $121,754 | 119 | $0 (2024) |
| ALBIREO PHARMA, INC. | $14,545 | 13 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2019) |
| Gilead Sciences, Inc. | $94.86 | 1 | $0 (2018) |
| GENZYME CORPORATION | $53.24 | 1 | $0 (2023) |
| Retrophin, Inc. | $19.08 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $62,211 | 76 | Mirum Pharmaceuticals, Inc. ($56,190) |
| 2023 | $49,668 | 42 | Mirum Pharmaceuticals, Inc. ($43,528) |
| 2022 | $24,474 | 15 | Mirum Pharmaceuticals, Inc. ($22,036) |
| 2019 | $125.00 | 1 | Alexion Pharmaceuticals, Inc. ($125.00) |
| 2018 | $113.12 | 3 | Gilead Sciences, Inc. ($94.86) |
| 2017 | $0.82 | 1 | Retrophin, Inc. ($0.82) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 2 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2024 | ALBIREO PHARMA, INC. | Bylvay (Drug) | Food and Beverage | In-kind items and services | $67.60 | General |
| Category: Gastroenterology | ||||||
| 08/25/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $3,250.00 | General |
| Category: Alagille syndrome | ||||||
| 08/25/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $3,080.00 | General |
| Category: Alagille syndrome | ||||||
| 08/25/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $106.86 | General |
| Category: Alagille syndrome | ||||||
| 08/25/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $85.99 | General |
| Category: Alagille syndrome | ||||||
| 08/25/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $38.76 | General |
| Category: Alagille syndrome | ||||||
| 08/25/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $33.64 | General |
| Category: Alagille syndrome | ||||||
| 08/25/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $18.83 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $116.46 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $69.64 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $5,200.00 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $2,925.00 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $385.00 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $143.48 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $137.00 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $118.66 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $76.54 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $37.24 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $28.26 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $26.45 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $22.99 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $20.86 | General |
| Category: Alagille syndrome | ||||||
| 06/10/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $37.70 | General |
| Category: Alagille syndrome | ||||||
| 05/20/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $3,080.00 | General |
| Category: Alagille syndrome | ||||||
| 05/20/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $2,695.00 | General |
| Category: Alagille syndrome | ||||||
About Dr. Jennifer Vittorio, M.D
Dr. Jennifer Vittorio, M.D is a Pediatric Transplant Hepatology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1285880450.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Vittorio, M.D has received a total of $136,591 in payments from pharmaceutical and medical device companies, with $62,211 received in 2024. These payments were reported across 138 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($107,576).
Ad
Practice Information
- Specialty Pediatric Transplant Hepatology
- Other Specialties Pediatric Gastroenterology, Internal Medicine
- Location New York, NY
- Active Since 08/07/2008
- Last Updated 05/23/2022
- Taxonomy Code 2080T0004X
- Entity Type Individual
- NPI Number 1285880450
Products in Payments
- Livmarli (Drug) $113,452
- Bylvay (Drug) $14,545
- Strensiq (Drug) $125.00
- DUPIXENT (Biological) $53.24
- (820) Cholbam (Drug) $19.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Transplant Hepatology Doctors in New York
Steven Lobritto, Md, MD
Pediatric Transplant Hepatology — Payments: $63,583
Pediatric Transplant Hepatology $63,583
Dr. Mercedes Martinez, Md, MD
Pediatric Transplant Hepatology — Payments: $16,952
Pediatric Transplant Hepatology $16,952
Pooja Reddy Spector, Md, Ms, MD, MS
Pediatric Transplant Hepatology — Payments: $584.27
Pediatric Transplant Hepatology $584.27
Adriana Perez, M.d, M.D
Pediatric Transplant Hepatology — Payments: $113.56
Pediatric Transplant Hepatology $113.56
Dr. Minoti Vather, Md, MD
Pediatric Transplant Hepatology
Pediatric Transplant Hepatology